ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,101.24
      -0.29%
      US Tech 100
      21,156.80
      -0.70%
      Dow Jones
      44,424.25
      -0.32%
      Brent Oil
      77.625
      0.00%
      Bitcoin
      104,946.20
      0.09%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Italy
      5. BIT

      6. Sanofi (SANF) Quote

      Sanofi

      Sanofi (SANF)

      BIT
      0.00
      0.00
      (0.00%)
      Closed January 25 11:30AM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      -
      Bid
      -
      Ask
      -
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Previous Close
      -
      Open
      -
      Last Trade
      Last Trade Time
      Average Volume (3m)
      -
      Financial Volume
      -
      VWAP
      -

      Ask ADVFN Intelligence (AI)

      SANF Latest News

      More News

      Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma

      Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma Sarclisa approved...

      January 22 2025
      UK Regulatory

      Communiqué de presse : Approbation du Sarclisa dans l’UE – premier anti-CD38 en association avec le schéma VRd de référence pour le traitement du myélome multiple nouvellement diagnostiqué de l’adulte non éligible à une greffe

      Communiqué de presse : Approbation du Sarclisa dans l’UE – premier anti-CD38 en association avec le schéma VRd de référence pour le traitement du myélome multiple nouvellement diagnostiqué de...

      January 22 2025
      UK Regulatory

      Press Release: Opella reaches study milestone for Cialis

      Press Release: Opella reaches study milestone for Cialis   Opella reaches study milestone for Cialis Paris, January 21, 2025. Opella, Sanofi’s Consumer Healthcare business, announced that the US...

      January 21 2025
      UK Regulatory

      Communiqué de presse : Opella : étape clé franchie pour l’étude consacrée au Cialis

      Communiqué de presse : Opella : étape clé franchie pour l’étude consacrée au Cialis Opella : étape clé franchie pour l’étude consacrée au Cialis Paris, le 21 janvier 2025. Opella, l’activité Santé...

      January 21 2025
      UK Regulatory

      Sanofi: Informations relatives au nombre de droits de vote et d'actions - Novembre 2024

      Sanofi: Informations relatives au nombre de droits de vote et d'actions - Novembre 2024 Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II...

      January 15 2025
      UK Regulatory

      Sanofi: Information concerning the total number of voting rights and shares – November 2024

      Sanofi: Information concerning the total number of voting rights and shares – November 2024 Information concerning the total number of voting rights and shares, provided pursuant to article L...

      January 15 2025
      UK Regulatory

      Communiqué de presse : Sarclisa : première approbation en Chine pour le traitement du myélome multiple en rechute ou réfractaire de l’adulte

      Communiqué de presse : Sarclisa : première approbation en Chine pour le traitement du myélome multiple en rechute ou réfractaire de l’adulte Sarclisa : première approbation en Chine pour le...

      January 13 2025
      UK Regulatory

      Press Release: Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma

      Press Release: Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma Sarclisa obtains first approval in China for the treatment...

      January 13 2025
      UK Regulatory

      Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma

      Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma New Sarclisa subcutaneous formulation met co-primary endpoints in the...

      January 09 2025
      UK Regulatory

      Communiqué de presse : La nouvelle formulation sous-cutanée du Sarclisa a satisfait aux co-critères d’évaluation primaires de l’étude de phase III IRAKLIA dans le myélome multiple

      Communiqué de presse : La nouvelle formulation sous-cutanée du Sarclisa a satisfait aux co-critères d’évaluation primaires de l’étude de phase III IRAKLIA dans le myélome multiple La nouvelle...

      January 09 2025
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DE
      40000000DE
      120000000DE
      260000000DE
      520000000DE
      1560000000DE
      2600000000DE

      SANF - Frequently Asked Questions (FAQ)

      What is the current Sanofi share price?
      The current share price of Sanofi is 0.00 €
      What is the 1 year trading range for Sanofi share price?
      Sanofi has traded in the range of 0.00 € to 0.00 € during the past year

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NTWNetweek SpA
      0.03 €
      (36.36%)
      		2.03M
      WSBCCSicily by Car SpA
      0.0336 €
      (29.73%)
      		502
      WSBCASicily by Car SpA
      0.028 €
      (27.27%)
      		2k
      1DDD3 D Sys Corp Dl 001
      3.60 €
      (24.27%)
      		8.68k
      1CIENCIENA Corp
      92.32 €
      (11.18%)
      		6
      1NKLANikola Corp
      0.84 €
      (-22.22%)
      		50.51k
      1VARVarta AG
      1.10 €
      (-19.12%)
      		113.28k
      WAMB26Ambromobiliare SpA
      0.0399 €
      (-18.90%)
      		5k
      WTWL26TraWell Co SpA
      0.19 €
      (-16.99%)
      		1.01k
      WNUS26Nusco Spa
      0.1116 €
      (-14.02%)
      		6k
      BMPSBanca Monte Dei Paschi Di Siena Spa
      6.504 €
      (-6.74%)
      		74.64M
      ISPIntesa Sanpaolo Spa
      4.1895 €
      (0.28%)
      		69.97M
      TITTelecom Italia SpA
      0.255 €
      (-1.73%)
      		54.14M
      SPMSaipem Spa
      2.416 €
      (-2.70%)
      		43.14M
      MBMediobanca Banca di Credito Finanziario SpA
      16.41 €
      (7.33%)
      		23.98M

      Discussion

      View Full Feed
      BullNBear52 BullNBear52 4 minutes ago
      I don't have sweat socks.

      I haven't heard that term since gym class in HS over 50 years ago.
      Living on love Living on love 4 minutes ago
      light reading...not advice...https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175712382
      ELTP
      RS500 RS500 4 minutes ago
      Yes here you are posting. Irony much?
      blackhawks blackhawks 5 minutes ago
      Perhaps because he responded to ICE questioning in 'code talk'?
      Chartmaster Chartmaster 5 minutes ago
      Hope UR RITE!.0048 by Wednesday!
      RITE
      KILLAZILLA KILLAZILLA 6 minutes ago
      you SAID. IF they RAN TESTS TO CERTIFY. THOSE TESTS WOULD BE HAVE TO BE MADE PUBLIC. SO, WHERE ARE THE RESULTS????

      THERE AREN'T ANY BECAUSE NO SUCH TESTING WAS DONE. NO SUCH TESTING WAS DONE BECAUSE SCAMBOARDS DON'T EXIST!!!!!!

      PATHETIC MAMALUKE!!!!
      AREN
      skyrocketinsight skyrocketinsight 7 minutes ago
      I think it is hard to come up with a value of how high in price of this stock will run until we find out
      The reasons that could propel the price to certain levels.
      The share price I think can go much higher than where we are now, but that all remains to be seen by whether the
      VGTL
      WarMachine WarMachine 7 minutes ago
      Still blowing smoke and won't provide sources for your false claim.
      Thanks for the confirmation. LOLZzzzzzzzzzzzz
      MONI
      ANTI-BAGHOLDER ANTI-BAGHOLDER 8 minutes ago
      Explain why you think Mypressalert is a joke...

      Go ahead... 

      Make a lagitamate claim and we can have real conversation.  


      MONI
      manibiotech manibiotech 8 minutes ago
      Yep 
      They are accountable to us not the other way around . Respect is a two way street . 
      NWBO
      wiwineguy wiwineguy 9 minutes ago
      style="color: rgba(0, 0, 0, 1); font-family: Georgia, serif; font-size: 18px; background-color: rgba(255, 255, 255, 1)"The Senate Energy and Natural Resources Committee voted Thursday to advance President Donald Trump’s nominees to lead the Interior and Energy Departments — with both nominees receiv
      TGLO
      Konaploinks Konaploinks 9 minutes ago
      IonQ’s acquisition of Qubitekk and their other partnerships with Nvda, University of Maryland and the State of Maryland and Duke University etc etc further cements Ionq’s lead in the Quantum Computing and Networking sector. With the advent of IonQ’s Quantum O S , their Quantum Hybrid Software Suite
      IONQ
      KILLAZILLA KILLAZILLA 9 minutes ago
      Trying to defend an OBVIOUS SCAM...PATHETIC!!!
      INQD
      jeunke22 jeunke22 10 minutes ago
      He told me his new job as a device engineer was very similar to what he was doing at Lightwave.
      I did ask if his new job was in anyway connected to Lightwave. He answered: “ I don’t think I can comment on that.” A simple “ NO” would have sufficed IMO , He choose to answer differently which k
      LWLG
      WOOFERHEAD WOOFERHEAD 10 minutes ago
      Hell yeah! Looks to be coming together sooner than I thought.

      I'm Loaded and ready for it.

      Let's Rock-N-Roll!

      GLTA

      $PTHRF PTHRF $PTHRF
      PTHRF
      splintered sunlight splintered sunlight 11 minutes ago
      Love to learn.

      How are they related?

      Thanks
      BBUZ
      joe botts joe botts 12 minutes ago
      Yep... this is NEVER going to trade again, that why it's just hysterical reading those posts.
      Carjockey2 Carjockey2 12 minutes ago
      $HMBL

      https://x.com/HUMBLPay/status/1882822372925034734?t=iZQhsKLobc6STCrfNQ8UoQ&s=19

      https://x.com/HUMBLPay/status/1882616158844776508?t=bs5JWvrpGPPzdYJ4ZmhE4Q&s=19
      HMBL

      Your Recent History

      BIT
      SANF
      Sanofi
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads